| Net earnings (loss) per share |
Note
13 – Net earnings (loss) per share
The
Company computes earnings (loss) per share of Class A Ordinary Shares and Class B Ordinary Shares using the two-class method. Except
as voting rights as discussed in Note 12, all other rights, including the liquidation and dividend rights, of the holders of Class A
Ordinary Shares and Class B Ordinary Shares are identical. As a result, the undistributed loss for each year is allocated based on the
contractual participation rights of the Class A Ordinary Shares and Class B Ordinary Shares as if the earnings for the year had been
distributed. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis.
The
following tables set forth the computation of basic and diluted loss per share of Class A Ordinary Shares and Class B Ordinary Shares:
Schedule of computation of basic and diluted loss per share
| | |
| | | |
| | |
| | |
For
the Six Months Ended
June
30, 2026 | |
| | |
Class
A
Ordinary
Shares | | |
Class
B
Ordinary
Shares | |
| | |
US$ | | |
US$ | |
| Basic
and diluted loss per share: | |
| | | |
| | |
| Numerator | |
| | | |
| | |
| Allocation
of undistributed loss | |
$ | (4,580,441 | ) | |
$ | (853,939 | ) |
| Denominator | |
| | | |
| | |
| Number
of shares used in per share computation | |
| 25,642,538 | | |
| 4,780,575 | |
| Basic
and diluted loss per share | |
$ | (0.18 | ) | |
$ | (0.18 | ) |
| | |
| | | |
| | |
| | |
For
the Six Months Ended
June
30, 2025 | |
| | |
Class
A
Ordinary
Shares | | |
Class
B
Ordinary
Shares | |
| | |
US$ | | |
US$ | |
| Basic
and diluted loss per share: | |
| | | |
| | |
| Numerator | |
| | | |
| | |
| Allocation
of undistributed loss | |
$ | (3,813,302 | ) | |
$ | (805,401 | ) |
| Denominator | |
| | | |
| | |
| Number
of shares used in per share computation | |
| 22,634,413 | | |
| 4,780,575 | |
| Basic
and diluted loss per share | |
$ | (0.17 | ) | |
$ | (0.17 | ) |
For
the six months ended June 30, 2026, the Company had dilutive securities from the outstanding convertible notes and warrants that are
convertible into 881,144 and 2,913,881 of the Company’s Class A Ordinary Shares, respectively, were not included in the computation
of dilutive loss per share because the inclusion of such convertible notes and warrants would be anti-dilutive.
The
summary of anti-dilutive instruments excluded from the computation of earnings per share, amount is as follows:
Summary of anti-dilutive instruments
| | |
Warrants | | |
Convertible
Notes | | |
Total | |
| Common
Stock subject to outstanding: | |
| | | |
| | | |
| | |
| For
six months ended June 30, 2026 | |
| 2,913,881 | | |
| 881,144 | | |
| 3,795,025 | |
| For
six months ended June 30, 2025 | |
| 4,949,156 | | |
| 1,409,815 | | |
| 6,358,971 | |
| Antidilutive securities excluded from computation of earnings per share, amount | |
| 4,949,156 | | |
| 1,409,815 | | |
| 6,358,971 | |
|